BioSpace News Archive

Titan Pharmaceuticals, Inc. and Crossroads of Southern Nevada rehabilitation facility announced that Crossroads has healthcare providers who are specially trained in the insertion and removal of Probuphine® implants, and will now offer Probuphine for use in eligible patients with Opioid Use Disorder.

Audentes Therapeutics, Inc. announced that Natalie Holles, President and Chief Operating Officer, will participate in the following investor conferences in October

Hill Holliday has made a key hire for its growing healthcare practice in Linda Bennett, it was announced by Hill Holliday president Chris Wallrapp.

Trial assessing safety and efficacy of onvansertib in combination with FOLFIRI and Avastin® (bevacizumab) in KRAS-mutated mCRC

Ferring Pharmaceuticals Inc. published a manuscript in the Journal of Managed Care & Specialty Pharmacy demonstrating that nocturia, defined as waking up ≥2 times for nighttime urination1, is associated with a substantial impact to the U.S. economy.

ITI-1000 targets CMV with Immunomic Therapeutics’ immunotherapy UNITE™ platform

Omeros Corporation announced that the product-specific J-code for OMIDRIA® 1% / 0.3% is now effective.

Meridian Medical Management announced that the newest version of VertexDr is 100% compliant with the latest regulations for Meaningful Use Stage 3 as well as the Promoting Interoperability reporting standards.

INVO Bioscience, Inc. announced that the Company will exhibit at the American Society for Reproductive Medicine 2019 Scientific Congress & Expo on October 12-16, 2019 in Philadelphia, PA at booth #1807 and the 20th World Congress of the International Society for In-Vitro Fertilization on October 24-26, 2019 in Barcelona, Spain at booth #15.

NeuroCycle Therapeutics, Inc. announced that it has been awarded a grant from the Helping to End Addiction Long-termsm Initiative, or the NIH HEAL Initiativesm, to advance development of its novel non-addictive treatment of chronic musculoskeletal pain.